Literature DB >> 1436463

Effects of radiotherapy determined by 11C-methyl-L-methionine positron emission tomography in patients with primary cerebral malignant lymphoma.

J Sawataishi1, K Mineura, T Sasajima, M Kowada, A Sugawara, F Shishido.   

Abstract

Two cases of histologically proven primary cerebral malignant lymphoma were examined serially with positron emission tomography (PET) using 11C-methyl-L-methionine (11C Met). Lesions delineated by 11C Met accumulation extended beyond enhancing areas on either X-ray computed tomography (CT) or magnetic resonance imaging. High uptake of 11C Met accurately showed biologically active and residual tumours, at a time when disappearance of a contrast-enhancing lesion on CT seemed to indicate involution. PET provides valuable information on the extent of tumour and assessment of radiotherapy in malignant lymphoma.

Entities:  

Mesh:

Year:  1992        PMID: 1436463     DOI: 10.1007/bf00598964

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  11 in total

Review 1.  Primary lymphoma of the central nervous system. Computerized tomography scan characteristics and treatment results for 12 cases.

Authors:  N P Mendenhall; T L Thar; O F Agee; B Harty-Golder; W E Ballinger; R R Million
Journal:  Cancer       Date:  1983-12-01       Impact factor: 6.860

2.  Radiation therapy for neoplasms of the brain.

Authors:  S A Leibel; G E Sheline
Journal:  J Neurosurg       Date:  1987-01       Impact factor: 5.115

3.  Primary cerebral lymphoma. A histologic and immunohistochemical study of six cases.

Authors:  J W Grant; P J Gallagher; D B Jones
Journal:  Arch Pathol Lab Med       Date:  1986-10       Impact factor: 5.534

4.  Incidence of lymphoma in the US classified by the working formulation.

Authors:  G R Newell; F G Cabanillas; F J Hagemeister; J J Butler
Journal:  Cancer       Date:  1987-02-15       Impact factor: 6.860

Review 5.  Primary central nervous system lymphoma.

Authors:  F H Hochberg; D C Miller
Journal:  J Neurosurg       Date:  1988-06       Impact factor: 5.115

6.  Positron emission tomography with ([11C]methyl)-L-methionine, [11C]D-glucose, and [68Ga]EDTA in supratentorial tumors.

Authors:  K Ericson; A Lilja; M Bergström; V P Collins; L Eriksson; E Ehrin; H von Holst; H Lundqvist; B Långsrom B; M Mosskin
Journal:  J Comput Assist Tomogr       Date:  1985 Jul-Aug       Impact factor: 1.826

7.  Primary malignant lymphoma of the central nervous system. Results of treatment of 11 cases and review of the literature.

Authors:  K Murray; L Kun; J Cox
Journal:  J Neurosurg       Date:  1986-11       Impact factor: 5.115

8.  Intracranial malignant lymphoma. Report of 30 cases and review of the literature.

Authors:  M Jiddane; F Nicoli; P Diaz; U Bergvall; F Vincentelli; J Hassoun; G Salamon
Journal:  J Neurosurg       Date:  1986-11       Impact factor: 5.115

9.  Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome.

Authors:  J E Baumgartner; J R Rachlin; J H Beckstead; T C Meeker; R M Levy; W M Wara; M L Rosenblum
Journal:  J Neurosurg       Date:  1990-08       Impact factor: 5.115

10.  High [18F]FDG uptake in primary cerebral lymphoma: a PET study.

Authors:  Y Kuwabara; Y Ichiya; M Otsuka; Y Miyake; R Gunasekera; K Hasuo; K Masuda; I Takeshita; H Fukui
Journal:  J Comput Assist Tomogr       Date:  1988 Jan-Feb       Impact factor: 1.826

View more
  6 in total

Review 1.  Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.

Authors:  P Rigo; P Paulus; B J Kaschten; R Hustinx; T Bury; G Jerusalem; T Benoit; J Foidart-Willems
Journal:  Eur J Nucl Med       Date:  1996-12

Review 2.  PET and SPECT imaging of the brain: a review on the current status of nuclear medicine in Japan.

Authors:  Tomohiro Kaneta
Journal:  Jpn J Radiol       Date:  2020-02-10       Impact factor: 2.374

Review 3.  Prediction of brain tumor therapy response by PET.

Authors:  R G Blasberg
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 4.  Positron emission tomography in patients with primary CNS lymphomas.

Authors:  U Roelcke; K L Leenders
Journal:  J Neurooncol       Date:  1999-07       Impact factor: 4.130

5.  Clinical impact of (11)C-methionine PET on expected management of patients with brain neoplasm.

Authors:  Tomohiko Yamane; Setsu Sakamoto; Michio Senda
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-11-14       Impact factor: 9.236

Review 6.  Positron Emission Tomography Imaging of Tumor Cell Metabolism and Application to Therapy Response Monitoring.

Authors:  Amarnath Challapalli; Eric O Aboagye
Journal:  Front Oncol       Date:  2016-02-29       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.